A detailed history of Deutsche Bank Ag\ transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 802,637 shares of FDMT stock, worth $6.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
802,637
Previous 124,339 545.52%
Holding current value
$6.75 Million
Previous $2.61 Million 232.54%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.81 - $27.22 $7.33 Million - $18.5 Million
678,298 Added 545.52%
802,637 $8.68 Million
Q2 2024

Aug 14, 2024

BUY
$20.93 - $30.01 $51,885 - $74,394
2,479 Added 2.03%
124,339 $2.61 Million
Q1 2024

May 15, 2024

SELL
$17.03 - $35.87 $6.22 Million - $13.1 Million
-365,133 Reduced 74.98%
121,860 $3.88 Million
Q4 2023

Feb 14, 2024

BUY
$9.76 - $21.25 $4.6 Million - $10 Million
471,424 Added 3027.97%
486,993 $9.87 Million
Q3 2023

Nov 09, 2023

SELL
$12.64 - $19.76 $8.35 Million - $13.1 Million
-660,584 Reduced 97.7%
15,569 $198,000
Q2 2023

Aug 14, 2023

BUY
$15.16 - $23.26 $9.03 Million - $13.9 Million
595,886 Added 742.38%
676,153 $12.2 Million
Q1 2023

May 15, 2023

BUY
$15.45 - $23.19 $81,854 - $122,860
5,298 Added 7.07%
80,267 $1.38 Million
Q4 2022

Feb 13, 2023

BUY
$6.85 - $25.46 $11,295 - $41,983
1,649 Added 2.25%
74,969 $1.67 Million
Q3 2022

Nov 14, 2022

BUY
$6.96 - $11.48 $417,787 - $689,109
60,027 Added 451.57%
73,320 $589,000
Q2 2022

Aug 11, 2022

SELL
$5.68 - $15.99 $12,643 - $35,593
-2,226 Reduced 14.34%
13,293 $93,000
Q1 2022

May 13, 2022

SELL
$13.16 - $22.64 $23,214 - $39,936
-1,764 Reduced 10.21%
15,519 $235,000
Q4 2021

Feb 11, 2022

BUY
$19.56 - $32.94 $8,254 - $13,900
422 Added 2.5%
17,283 $379,000
Q3 2021

Nov 04, 2021

BUY
$22.73 - $36.04 $141,380 - $224,168
6,220 Added 58.45%
16,861 $454,000
Q2 2021

Aug 11, 2021

BUY
$22.2 - $42.29 $20,646 - $39,329
930 Added 9.58%
10,641 $257,000
Q1 2021

May 13, 2021

BUY
$35.94 - $52.67 $349,013 - $511,478
9,711 New
9,711 $421,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $272M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.